Literature DB >> 18272623

Do you approve of spending $300 million on HPV vaccination?: no.

Abby Lippman1, Madeline Boscoe, Carol Scurfield.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18272623      PMCID: PMC2278297     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  10 in total

1.  Cervical cancer mortality by neighbourhood income in urban Canada from 1971 to 1996.

Authors:  Edward Ng; Russell Wilkins; Michael Fung Kee Fung; Jean-Marie Berthelot
Journal:  CMAJ       Date:  2004-05-11       Impact factor: 8.262

2.  Human papillomavirus, vaccines and women's health: questions and cautions.

Authors:  Abby Lippman; Ryan Melnychuk; Carolyn Shimmin; Madeline Boscoe
Journal:  CMAJ       Date:  2007-08-01       Impact factor: 8.262

3.  Essential elements of a technology and outcomes assessment initiative.

Authors:  Ezekiel J Emanuel; Victor R Fuchs; Alan M Garber
Journal:  JAMA       Date:  2007-09-19       Impact factor: 56.272

Review 4.  Process of care failures in invasive cervical cancer: systematic review and meta-analysis.

Authors:  Andrea R Spence; Patricia Goggin; Eduardo L Franco
Journal:  Prev Med       Date:  2007-06-22       Impact factor: 4.018

5.  Limits on autonomy: political meta-narratives and health stories in the media.

Authors:  Sharon Batt
Journal:  Am J Bioeth       Date:  2007-08       Impact factor: 11.229

Review 6.  Challenges of implementing human papillomavirus (HPV) vaccination policy.

Authors:  Angela E Raffle
Journal:  BMJ       Date:  2007-08-25

Review 7.  Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing.

Authors:  Mark Schiffman
Journal:  Cancer       Date:  2007-06-25       Impact factor: 6.860

8.  Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial.

Authors:  Keith S Reisinger; Stan L Block; Eduardo Lazcano-Ponce; Rudiwilai Samakoses; Mark T Esser; Joanne Erick; Derek Puchalski; Katherine E D Giacoletti; Heather L Sings; Suzanne Lukac; Frances B Alvarez; Eliav Barr
Journal:  Pediatr Infect Dis J       Date:  2007-03       Impact factor: 2.129

Review 9.  Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing.

Authors:  Cosette M Wheeler
Journal:  Nat Clin Pract Oncol       Date:  2007-04

10.  Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

Authors:  Marie-Hélène Mayrand; Eliane Duarte-Franco; Isabel Rodrigues; Stephen D Walter; James Hanley; Alex Ferenczy; Sam Ratnam; François Coutlée; Eduardo L Franco
Journal:  N Engl J Med       Date:  2007-10-18       Impact factor: 91.245

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.